Engineered Alpha-Synuclein Mouse Models Reshape Parkinson’s Therapy Testing
A new review details how engineered alpha-synuclein mouse models with defined biochemical defects are transforming Parkinson's disease therapy development.
A new review details how engineered alpha-synuclein mouse models with defined biochemical defects are transforming Parkinson's disease therapy development.
Observational neurocritical care data suggest maintaining cerebral perfusion pressure near 80 millimeters of mercury may prevent secondary brain tissue hypoxia ...
A comprehensive bibliometric analysis of 9,533 publications reveals that futures studies has grown at twice the rate of science in ...
Chemotherapy activates cGAS–STING in head and neck cancer cells, driving TNF release, IKKβ-mediated ATG9A S654 phosphorylation and autophagy that promotes ...
Researchers have engineered a renewable cooling lubricant formulation using plant-derived diols that successfully prevents microbial spoilage through biostatic inhibition during ...
A deep learning-based optimization scheme redesigned the tip and root airfoils of the Helishape-7A helicopter rotor, raising hover thrust coefficient ...
A large UK Biobank study finds medial knee joint space width is the compartment-specific measure most strongly associated with clinical ...
A Brazilian multicenter study found that over one-third of rheumatoid arthritis patients meeting clinical treat-to-target goals by SDAI were classified ...
A pilot randomized controlled trial in Ethiopia found that an interprofessional rehabilitation program for chronic low back pain was feasible ...
Researchers have developed a multi-stage hierarchical reinforcement learning framework that enables aerial drones to guide quadruped ground robots through simulated ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine